Flumazenil MarketSize and Trends

Global flumazenil market is estimated to be valued at US$ 20.528 Mn in 2022 and is expected to exhibit a CAGR of 2.8% over the forecast period (2022-2030)

Figure 1: Global Flumazenil Market Share, (%), Analysis, By Application, 2022

Market players are concentrating on launching of new products. This is expected to drive growth of the global flumazenil market over the forecast period.

Market players are launching new products, which is expected to drive growth of the global flumazenil market over the forecast period. For instance, in January 2018, Hikma Pharmaceuticals, a developer of medicines, had launched its product Flumazenil Injection, USP 0.5 mg/5 mL. Flumazenil Injection contain active ingredients such as flumazenil and inactive ingredients such as acetic acid, hydrochloric acid, sodium hydroxide, methylparaben, sodium chloride, propylparaben, and edetate disodium. Flumazenil, is an imidazobenzodiazepine derivative, which disaffects the actions of benzodiazepines on the central nervous system.

Increasing number of anxiety disorders among people is expected to drive growth of the global flumazenil market over the forecast period.

Increasing number of people with anxiety disorders is expected to propel growth of the global flumazenil market over the forecast period. For instance, according to data published in April 2018, by Our World in Data, a scientific online publication, about 284 million people were suffering from anxiety disorders globally in the year 2017. For the treatment of anxiety disorders antidepressant drugs such as benzodiazepines are prescribed for the patient. Flumazenil is used as a general anesthesia for complete or partial reversal of the sedative effects caused by benzodiazepines in patients, which it is expected drive growth of the global flumazenil market.

Market Trends

Global Flumazenil Market – Market Trends